Impact Of A Pharmacological Cardioversion With Vernakalant On The Management Cost Of Recent Atrial Fibrillation In Belgium
Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.1447
https://www.valueinhealthjournal.com/article/S1098-3015(14)03377-4/fulltext
Section Title :
Disease-Specific Studies
Section Order :
930
First Page :
A490
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03377-4&doi=10.1016/j.jval.2014.08.1447